Direct-acting Antiviral Agents in Hepatitis C Virus-infected Renal Allograft Recipients: Treatment and Outcome Experience from Single Center

Hepatitis C virus (HCV) infection in renal allograft recipient is associated with increased morbidity and mortality. At present, only few studies related to treatment and outcomes of HCV-infected renal allograft recipients with DAAs have been published. We aimed the study to assess the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, N., Patel, M. R., Pandey, A., Jaiswal, A., Bhadauria, D., Kaul, A., Sharma, R. K., Mohindra, S., Pandey, G., Goel, A., Gupta, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998719/
https://www.ncbi.nlm.nih.gov/pubmed/29962673
http://dx.doi.org/10.4103/ijn.IJN_190_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998719/
https://www.ncbi.nlm.nih.gov/pubmed/29962673
http://dx.doi.org/10.4103/ijn.IJN_190_17

Ejemplares similares